Uppsala, Sweden

Nils Norrman

USPTO Granted Patents = 27 

 

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 153(Granted Patents)


Company Filing History:


Years Active: 2009-2023

Loading Chart...
Loading Chart...
27 patents (USPTO):

Title: Nils Norrman: Innovator in Biomolecule Separation Technologies

Introduction

Nils Norrman, based in Uppsala, Sweden, is a distinguished inventor with a portfolio of 27 patents. His contributions primarily focus on advancements in biomolecule separation technologies, which are critical in various biomedical applications and research.

Latest Patents

Among his latest innovations, Nils Norrman has developed remarkable inventions such as "Magnetic Immunoglobulin-Binding Particles." This invention features an immunoglobulin-binding magnetic bead, incorporating a porous matrix with embedded magnetic particles and functionalized with Fc-binding proteinaceous ligands. Another notable patent is the "Method and System for Separating Biomolecules," which provides a comprehensive method for separating biomolecules from cell cultures using magnetic beads. This invention outlines processes for integrating a magnetic separator and an elution arrangement, enhancing the efficiency of biomolecule extraction.

Career Highlights

Norrman has held significant positions in reputable companies such as GE Healthcare Biosciences AB and GE Healthcare Bioprocess R&D AB. His work in these organizations has allowed him to refine his expertise in bioprocessing and separation technologies, making substantial contributions to the fields of biomedical engineering and biotechnology.

Collaborations

Throughout his career, Nils has collaborated with highly regarded professionals, including Gunnar Glad and Bo-Lennart Johansson. These partnerships have further strengthened his innovative approach and propelled successful developments in his projects.

Conclusion

Nils Norrman's inventive spirit and expertise in biomolecule separation technologies exemplify the impact of dedicated inventors in the life sciences sector. His 27 patents reflect a commitment to advancing technology that enhances biomedical research, showcasing the importance of innovation in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…